ACS had a key presence at global oncology conference.
June 3 marks the start of the American Society of Clinical Oncology Annual Meeting, held online and in person through June 7. With more than 40,000 oncology professionals from around the world attending, this meeting is one of the largest, most diverse in global oncology. For the American Cancer Society, it is an opportunity to drive awareness of our organization’s relevance and impact across the cancer care continuum.
The theme of the 2022 annual meeting is “Advancing Equitable Cancer Care Through Innovation,” and will focus on how by innovating across boundaries, we can bring down barriers to access and make care more equitable, convenient, and efficient for patients worldwide. Attendees include ASCO members, National Cancer Institute-designated cancer centers, cancer care clinicians, pharmaceutical company representatives, and advocacy groups.
ACS will have a strong presence at the event, with nearly a dozen staff and ACS-funded researchers presenting during the meeting. The organization will also host a reception for key partners as well as a booth in the exhibition hall to demonstrate how the organization is impacting the lives of people facing cancer.
A key goal of the organization’s presence at the meeting is to emphasize ACS is the only organization that integrates advocacy, discovery, and direct patient support, which measurably improves lives, and that as a global leader in the cancer fight, we know cancer affects everyone, but it doesn’t affect everyone equally. We are working to ensure everyone has a fair and just opportunity to prevent, detect, treat, and survive cancer.
ASCO is an important partner for ACS. In early 2022, the two organizations launched a collaboration involving content-sharing on ASCO’s cancer.net and cancer.org.
ACS staff and ACS-funded researchers presenting at the conference:
Be sure to follow along on social media to see the latest from ASCO during the next few days.
ASCO social channels:
For questions related to ACS participation at ASCO, please contact Kathleen Goss, vice president, regional cancer support.